Table 3.
Clinicoradiographic Assessment After PCC | Patients |
|
---|---|---|
No. | % | |
Primary tumor | ||
CR | 30 | 70 |
PR | 13 | 30 |
Stable disease | 0 | 0 |
Neck | ||
CR | 10 | 22 |
PR | 34 | 74 |
Stable disease | 2 | 4 |
Overall response (primary tumor and neck) | ||
CR | 9 | 19 |
PR | 36 | 77 |
Stable disease | 2 | 4 |
Abbreviations: PCC, paclitaxel, carboplatin, and cetuximab; CR, complete response; PR, partial response.